Status | Study |
Active, not recruiting |
Study Name: Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer Condition: Adult Hepatocellular Carcinoma Advanced Adult Hepatocellular Carcinoma Date: 2009-11-06 Interventions: Biological: Bevacizumab Given |
Completed |
Study Name: Doxorubicin Beads in Treating Patients With Unresectable Liver Metastases From Neuroendocrine Tumors Condition: Gastrointestinal Carcinoid Tumor Islet Cell Tumor Metastat Date: 2008-08-07 Interventions: Drug: PVA microporous hydrospheres/doxorubicin hydrochloride |
Active, not recruiting |
Study Name: Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors Condition: Gastrinoma Glucagonoma Insuli Date: 2008-04-09 Interventions: Drug: everolimus Given orally |
Completed |
Study Name: Capecitabine and Streptozocin With or Without Cisplatin in Treating Patients With Unresectable or Metastatic Neuroendocrine Tumors Condition: Gastrointestinal Carcinoid Tumor Islet Cell Tumor Date: 2008-01-25 Interventions: Drug: capecitabine Drug: cisplatin |
Completed |
Study Name: Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain Condition: Cancer Date: 2007-10-01 Interventions: Drug: Fentanyl sublingual spray |
Terminated |
Study Name: Internal Radiation Therapy in Treating Patients With Liver Metastases From Neuroendocrine Tumors Condition: Head and Neck Cancer Islet Cell Tumor Metastatic Cancer Date: 2007-04-25 Interventions: Drug: octreotide acetate |
Completed |
Study Name: Pazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine Cancer Condition: Gastrin-Producing Neuroendocrine Tumor Lung Carcinoid Tumor Date: 2007-03-27 Interventions: Other: Laboratory Biomarker Analysis |
Terminated |
Study Name: Disease-Specific Questionnaire in Assessing Quality of Life in Patients With Gastrointestinal-Related Neuroendocrine Tumors Condition: Gastrointestinal Carcinoid Tumor Islet Cell Tumor Lung Can Date: 2007-03-27 Interventions: Other: questionnaire administration Proced |
Completed |
Study Name: AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors Condition: Gastrointestinal Carcinoid Tumor Islet Cell Tumor Neoplast Date: 2007-01-25 Interventions: Drug: AMG 706 AMG 706 was admi |
Completed |
Study Name: Combination Chemotherapy as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors of the Duodenum or Pancreas That Cannot Be Removed By Surgery Condition: Gastrointestinal Carcinoid Tumor Islet Cell Tumor Neoplast Date: 2006-12-27 Interventions: Drug: fluorouracil Drug: irinotecan hydroc |